COAGULOPATHY
Clinical trials for COAGULOPATHY explained in plain language.
Never miss a new study
Get alerted when new COAGULOPATHY trials appear
Sign up with your email to follow new studies for COAGULOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Battlefield plasma goes civilian: can powdered blood save trauma patients?
Disease control CompletedThis study tested a freeze-dried plasma product, originally developed for military use, in 42 trauma patients with severe bleeding. The goal was to see if this quick-to-prepare plasma could help control bleeding better than standard frozen plasma. The approach aims to make life-s…
Matched conditions: COAGULOPATHY
Phase: PHASE3 • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated May 17, 2026 14:13 UTC
-
Can a special plasma fix clotting in septic shock? new study explores.
Disease control CompletedThis study tested whether a special donor plasma product (OctaplasLG) can help correct dangerous blood clotting problems in people with septic shock. The trial included 60 adults with septic shock and clotting issues. Researchers measured how quickly treatment was given and track…
Matched conditions: COAGULOPATHY
Phase: NA • Sponsor: University Hospital, Strasbourg, France • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Could whole blood be just as good as standard transfusions for trauma patients?
Disease control CompletedThis study looked at whether giving whole blood (all blood parts together) works as well as giving separate blood products (red cells, plasma, platelets) to trauma patients with severe bleeding. About 200 adults with major injuries were included. The goal was to see if whole bloo…
Matched conditions: COAGULOPATHY
Phase: PHASE3 • Sponsor: Direction Centrale du Service de Santé des Armées • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New powdered plasma passes early safety check in healthy volunteers
Knowledge-focused CompletedThis early-stage study tested the safety of a new spray-dried plasma product called FrontlineODP in 24 healthy adults. Participants received one, two, or four units of the product, and their safety was compared to those receiving standard frozen plasma. The goal was to see if the…
Matched conditions: COAGULOPATHY
Phase: PHASE1 • Sponsor: Velico Medical • Aim: Knowledge-focused
Last updated May 17, 2026 14:15 UTC
-
Sepsis study reveals hidden link between tiny vessels and clotting
Knowledge-focused CompletedThis study looked at 30 adults with sepsis to understand how tiny blood vessel damage and blood clotting problems are connected. Researchers used a special camera under the tongue to see small vessels and measured blood clotting. The goal was to learn more about these relationshi…
Matched conditions: COAGULOPATHY
Sponsor: Università Politecnica delle Marche • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC